|
US10834922B2
(en)
*
|
2014-11-26 |
2020-11-17 |
Microban Products Company |
Surface disinfectant with residual biocidal property
|
|
SG10201913266UA
(en)
|
2015-12-11 |
2020-02-27 |
Massachusetts Eye & Ear Infirmary |
Materials and methods for delivering nucleic acids to cochlear and vestibular cells
|
|
EP3510161A4
(en)
|
2016-08-23 |
2020-04-22 |
Akouos, Inc. |
COMPOSITIONS AND METHODS FOR TREATING PERSONAL HEARING LOSS IN A PERSON
|
|
WO2018145111A1
(en)
*
|
2017-02-06 |
2018-08-09 |
Children's Medical Center Corporation |
Materials and methods for delivering nucleic acids to cochlear and vestibular cells
|
|
JP2020509786A
(ja)
*
|
2017-03-17 |
2020-04-02 |
レスキュー ヒヤリング インコーポレイテッド |
聴覚損失の治療のための遺伝子治療構成物および方法
|
|
US12391936B2
(en)
|
2017-03-17 |
2025-08-19 |
Rescue Hearing, Inc. |
Gene therapy systems and related methods for treatment of hearing loss
|
|
KR102606810B1
(ko)
|
2017-05-05 |
2023-11-27 |
유니버시티 오브 플로리다 리서치 파운데이션, 인코포레이티드 |
오토펄린을 발현시키기 위한 조성물 및 방법
|
|
US20210154326A1
(en)
*
|
2017-06-26 |
2021-05-27 |
Arizona Board Of Regents On Behalf Of Arizona State University |
CRISPR-Based Synthetic Gene Circuits as Next Generation Gene Therapy of Inner Ear
|
|
EP3661523A4
(en)
*
|
2017-08-03 |
2021-08-04 |
University of Iowa Research Foundation |
TREATMENT METHODS FOR GENETIC HEARING LOSS
|
|
EP3727468A4
(en)
|
2017-12-19 |
2021-09-22 |
Akouos, Inc. |
AAV-MEDIATED THERAPEUTIC ANTIBODIES DELIVERY TO THE INTERNAL EAR
|
|
DE102018100619A1
(de)
|
2018-01-12 |
2019-07-18 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin |
Gentherapeutische Behandlung von Schwerhörigkeit
|
|
AU2019209770B2
(en)
|
2018-01-16 |
2025-07-31 |
Cls Therapeutics Limited |
Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity
|
|
DE102018103924A1
(de)
|
2018-02-21 |
2019-08-22 |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin |
Gentherapeutische Behandlung von Schwerhörigkeit
|
|
EP3762040A4
(en)
*
|
2018-03-05 |
2022-01-05 |
Children's Medical Center Corporation |
COMPOSITIONS AND METHODS OF ADMINISTRATION OF NUCLEIC ACIDS TO COCHLEAR AND VESTIBULAR CELLS
|
|
BR112020019079A2
(pt)
|
2018-03-23 |
2020-12-29 |
Massachusetts Eye And Ear Infirmary |
Abordagem de salto de éxon mediada por crispr/cas9 para síndrome de usher associada a ush2a
|
|
WO2019200016A1
(en)
*
|
2018-04-10 |
2019-10-17 |
President And Fellows Of Harvard College |
Aav vectors encoding clarin-1 or gjb2 and uses thereof
|
|
US11660353B2
(en)
|
2018-04-27 |
2023-05-30 |
Decibel Therapeutics, Inc. |
Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems
|
|
CN112703016B
(zh)
*
|
2018-04-27 |
2024-11-22 |
分贝治疗公司 |
肌球蛋白15启动子及其用途
|
|
CA3100006A1
(en)
*
|
2018-05-11 |
2019-11-14 |
Massachusetts Eye And Ear Infirmary |
Altering tissue tropism of adeno-associated viruses
|
|
US20210277417A1
(en)
*
|
2018-06-25 |
2021-09-09 |
Akouos, Inc. |
Methods of treating clrn1-associated hearing loss and/or vision loss
|
|
WO2020014625A1
(en)
*
|
2018-07-13 |
2020-01-16 |
Akouos, Inc. |
Methods of treating non-syndromic sensorineural hearing loss
|
|
US20210290727A1
(en)
*
|
2018-08-01 |
2021-09-23 |
University Of Maryland, Baltimore |
MODULATION OF mTORCI ACTIVITY AND AUTOPHAGY VIA CIB2-RHEB INTERACTION
|
|
EP3856227A4
(en)
*
|
2018-09-27 |
2022-07-06 |
Akouos, Inc. |
METHODS OF TREATMENT OF AUDITORY NEUROPATHY SPECTRUM DISEASE
|
|
WO2020077295A1
(en)
*
|
2018-10-11 |
2020-04-16 |
Decibel Therapeutics, Inc. |
Aav1 vectors and uses thereof for treatment of otic indications
|
|
EP3880827A4
(en)
*
|
2018-11-07 |
2023-04-26 |
Akouos, Inc. |
COMPOSITIONS AND METHODS FOR INDUCING DIFFERENTIATION OF A HAIR CELL
|
|
EP4063510A1
(en)
*
|
2018-11-07 |
2022-09-28 |
Akouos, Inc. |
Use of adeno-associated viral vectors to correct gene defects/ express proteins in hair cells and supporting cells in the inner ear
|
|
EP4295913A3
(en)
|
2019-01-18 |
2024-03-06 |
Institut Pasteur |
Aav-mediated gene therapy restoring the otoferlin gene
|
|
CA3129422A1
(en)
|
2019-02-08 |
2020-08-13 |
Decibel Therapeutics, Inc. |
Myosin 15 promoters and uses thereof
|
|
EP3921032A4
(en)
*
|
2019-02-08 |
2022-11-30 |
Decibel Therapeutics, Inc. |
COMPOSITIONS AND METHODS FOR TREATMENT OF SENSORINEURAL HEARING LOSS USING OTOFERLIN DOUBLE VECTOR SYSTEMS
|
|
US20220202957A1
(en)
*
|
2019-04-09 |
2022-06-30 |
The Regents Of The University Of California |
Long-lasting analgesia via targeted in vivo epigenetic repression
|
|
CN110129368B
(zh)
*
|
2019-04-22 |
2021-03-09 |
中国科学院脑科学与智能技术卓越创新中心 |
一种感染支持细胞和毛细胞的aav载体
|
|
US11278013B2
(en)
|
2019-04-26 |
2022-03-22 |
Usher 2020 Foundation |
Large animal model for developing therapeutic agents to treat impaired ophthalmic function in usher syndrome
|
|
EP3959324B1
(en)
|
2019-04-26 |
2025-09-17 |
President and Fellows of Harvard College |
Aav vectors encoding mini-pcdh15 and uses thereof
|
|
WO2020223933A1
(zh)
*
|
2019-05-08 |
2020-11-12 |
中国科学院脑科学与智能技术卓越创新中心 |
高效感染支持细胞的aav突变体
|
|
EP3999647A1
(en)
*
|
2019-07-18 |
2022-05-25 |
Lysogene |
Compositions and methods for the treatment of sanfilippo disease and other disorders
|
|
CN110423778B
(zh)
*
|
2019-07-26 |
2023-04-21 |
上海科技大学 |
一种逆行性重组2型腺相关病毒在感染螺旋神经元中的应用
|
|
CA3153972A1
(en)
|
2019-09-09 |
2021-03-18 |
Massachusetts Eye And Ear Infirmary |
Methods and compositions for modulating the interaction between adeno-associated virus (aav) and the aav receptor (aavr) for altered bio-distribution of aav
|
|
WO2021067448A1
(en)
|
2019-09-30 |
2021-04-08 |
Applied Genetic Technologies Corporation |
Adeno-associated virus (aav) systems for treatment of genetic hearing loss
|
|
AU2020366531A1
(en)
*
|
2019-10-18 |
2022-05-26 |
Research Institute At Nationwide Children's Hospital |
Gene therapy targeting cochlear cells
|
|
KR20220130093A
(ko)
|
2019-10-30 |
2022-09-26 |
데시벨 테라퓨틱스, 인크. |
오토펄린 듀얼 벡터 시스템을 사용한 감각신경성 난청을 치료하기 위한 조성물 및 방법
|
|
EP4055175A4
(en)
|
2019-11-04 |
2023-11-29 |
Decibel Therapeutics, Inc. |
Cochlear inner hair cell promoters and uses thereof
|
|
TWI902721B
(zh)
*
|
2019-11-04 |
2025-11-01 |
美商迪賽博治療公司 |
前庭支持細胞啟動子及其用途
|
|
WO2021108512A1
(en)
*
|
2019-11-27 |
2021-06-03 |
Icahn School Of Medicine At Mount Sinai |
Gene therapy for the regeneration of auditory hair cells
|
|
US20230047254A1
(en)
*
|
2019-12-29 |
2023-02-16 |
Gloriana Therapeutics |
Mammalian Cells Secreting GDNF and Their Therapeutic Use
|
|
KR20220157944A
(ko)
|
2020-02-21 |
2022-11-29 |
아카우오스, 인크. |
인간 대상체에서 비-연령-연관 청각 장애를 치료하기 위한 조성물 및 방법
|
|
CN115666658A
(zh)
|
2020-04-01 |
2023-01-31 |
佛罗里达州大学研究基金会 |
具有提高的治疗ush1b的安全性的双aav-myo7a载体
|
|
WO2021222682A1
(en)
*
|
2020-04-30 |
2021-11-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Application of aav44.9 vector in gene therapy for the inner ear
|
|
IL298128A
(en)
*
|
2020-05-13 |
2023-01-01 |
Akouos Inc |
Compositions and methods for treating slc26a4-associated hearing loss
|
|
WO2021231538A2
(en)
*
|
2020-05-13 |
2021-11-18 |
Akouos, Inc. |
Compositions and methods for treating kcnq4-associated hearing loss
|
|
WO2021231808A2
(en)
*
|
2020-05-13 |
2021-11-18 |
Akouos, Inc. |
Compositions and methods for treating gjb2-associated hearing loss
|
|
KR102326582B1
(ko)
*
|
2020-05-15 |
2021-11-16 |
사회복지법인 삼성생명공익재단 |
청각장애의 진단용 마커 및 그의 용도
|
|
WO2022032151A1
(en)
*
|
2020-08-07 |
2022-02-10 |
University Of Miami |
Treatment of sensorineural deafness
|
|
US12129287B2
(en)
|
2020-09-14 |
2024-10-29 |
President And Fellows Of Harvard College |
Recombinant adeno associated virus encoding clarin-1 and uses thereof
|
|
IL303317A
(en)
|
2020-12-01 |
2023-07-01 |
Akouos Inc |
ANTI-NATURAL ANTIBODY STRUCTURES AND RELATED METHODS FOR THE TREATMENT OF SYMPTOMS ASSOCIATED WITH VESTIBULAR SWANNOMA
|
|
EP4262882A1
(en)
*
|
2020-12-18 |
2023-10-25 |
Institut Pasteur |
Gene therapy for treating usher syndrome
|
|
CA3216712A1
(en)
*
|
2021-04-14 |
2022-10-20 |
Research Institute At Nationwide Children's Hospital |
Materials and methods for neurofibromin 2/merlin (nf2) gene therapy
|
|
AU2022271238A1
(en)
*
|
2021-05-04 |
2023-12-14 |
Decibel Therapeutics, Inc. |
Vestibular supporting cell promoters and uses thereof
|
|
CN113604469B
(zh)
*
|
2021-08-11 |
2023-01-24 |
复旦大学附属眼耳鼻喉科医院 |
基于CRISPR/CasRx的基因编辑方法及其应用
|
|
EP4409009A4
(en)
*
|
2021-09-30 |
2025-12-17 |
Akouos Inc |
Compositions for administering gene therapy and methods for treating hearing loss
|
|
US20250073354A1
(en)
*
|
2021-12-23 |
2025-03-06 |
University Of Rochester |
Compositions and methods for delivery of agents to inner ear
|
|
WO2023147383A1
(en)
|
2022-01-25 |
2023-08-03 |
Bridgebio Services Inc. |
Gene therapy for genetic hearing loss
|
|
GB202214972D0
(en)
*
|
2022-10-11 |
2022-11-23 |
Ucl Business Ltd |
Products and methods for use in treating NDP-related diseases
|
|
WO2024151703A2
(en)
*
|
2023-01-12 |
2024-07-18 |
Ohio State Innovation Foundation |
Gene therapy for treating hearing loss disorders
|
|
CN121311586A
(zh)
*
|
2023-05-12 |
2026-01-09 |
苏州星奥拓维生物技术有限公司 |
耳蜗內毛细胞特异性启动子及其应用
|
|
CN121816425A
(zh)
|
2023-09-11 |
2026-04-07 |
学校法人顺天堂 |
能够感染内耳的aav变体
|
|
WO2025085845A1
(en)
*
|
2023-10-19 |
2025-04-24 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Gene therapy for hearing loss and vestibular disorders
|
|
US20250276095A1
(en)
|
2024-03-04 |
2025-09-04 |
Kate Therapeutics, Inc. |
Adeno-associated virus compositions for the treatment of duchenne muscular dystrophy
|
|
WO2025226842A1
(en)
|
2024-04-24 |
2025-10-30 |
Kate Therapeutics, Inc. |
Expression control by drg-expressed mirnas
|
|
WO2025226841A1
(en)
|
2024-04-24 |
2025-10-30 |
Kate Therapeutics, Inc. |
Gene therapy approach for treating disorders associated with tnnt2
|
|
WO2026011008A1
(en)
|
2024-07-02 |
2026-01-08 |
Kate Therapeutics, Inc. |
Expression control by skeletal muscle-expressed mirnas
|
|
WO2026011009A1
(en)
|
2024-07-02 |
2026-01-08 |
Kate Therapeutics, Inc. |
Compositions and methods for muscle disorders
|
|
WO2026030242A1
(en)
|
2024-07-29 |
2026-02-05 |
Kate Therapeutics, Inc. |
Adeno-associated virus compositions for the treatment of facioscapulohumeral muscular dystrophy
|
|
WO2026030244A1
(en)
|
2024-07-30 |
2026-02-05 |
Kate Therapeutics, Inc. |
Adeno-associated virus compositions for the treatment of limb girdle muscular dystrophy 2a
|
|
WO2026050402A1
(en)
|
2024-08-29 |
2026-03-05 |
Kate Therapeutics, Inc. |
Liver de-targeted muscle tropic capsids
|